NCT00351650View on ClinicalTrials.gov

Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 9, 2006

Study Completion Date

February 6, 2008

Conditions
Type I Diabetes
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00351650 - Assessment of Beta Cell Mass in Type 1 Diabetes With 11C-Dihydrotetrabenazine and PET Scan | Biotech Hunter | Biotech Hunter